0.2499
-0.0001 (-0.04%)
-0.0001 (-0.04%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Heat Biologics Inc | HTBX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.0003 | 0.12% | 0.25 | 0.244601 | 0.2549 | 0.245 | 0.2497 | 19:59:26 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 0.249 | 0.2499 | 0.0009 | 0.36% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,228 | 729,320 | $ 0.2487156 | $ 181,393 | 1,571,365 | 0.2295 - 1.86 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:47:41 | 10 | $ 0.2499 | USD |
Heat Biologics Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 14.36M | 57.42M | $ -15.73M | -1.28 | - | 55.00M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | 7.10% |
Heat Biologics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HTBX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.2589 | 0.27 | 0.239 | 0.2486952 | 849,290 | -0.0089 | -3.44% |
| 1 Month | 0.333 | 0.35 | 0.2295 | 0.2653033 | 1,729,135 | -0.083 | -24.92% |
| 3 Months | 0.45 | 0.5275 | 0.2295 | 0.3156495 | 890,930 | -0.20 | -44.44% |
| 6 Months | 0.562 | 0.65 | 0.2295 | 0.3641281 | 541,156 | -0.312 | -55.52% |
| 1 Year | 1.40 | 1.86 | 0.2295 | 0.6993799 | 498,518 | -1.15 | -82.14% |
| 3 Years | 9.306 | 12.50 | 0.2295 | 3.07 | 606,947 | -9.06 | -97.31% |
| 5 Years | 58.70 | 109.00 | 0.2295 | 8.62 | 670,162 | -58.45 | -99.57% |
Heat Biologics Description
| Heat Biologics Inc is a US-based immuno-oncology company. It is engaged in developing therapies which activate a patient's immune system against cancer utilizing an engineered form of gp96. The group's T cell-stimulating therapeutic vaccine platform technologies, Immune Pan-Antigen Cytotoxic Therapy (ImPACT) and Combination Pan-Antigen Cytotoxic Therapy (ComPACT), form the basis of its product candidates. Through ImPACT, it developed product candidates consisting of live, genetically-modified, irradiated human cancer cells which secrete tumor-associated antigens together with an immune response stimulator called gp96. Through ComPACT, the firm engineered product candidates that incorporate ligand fusion proteins targeting co-stimulatory receptors into the gp96-Ig expression vector. |
